STAT+: How a Trump loyalist got the FDA nomination

STAT PlusNewsletterD.C. Diagnosis How a Trump loyalist got the FDA nomination You’re reading STAT’s D.C. Diagnosis newsletter Manage alerts for this article Email this article Share this article By John WilkersonAug.

20, 2026 Washington Correspondent John Wilkerson[email protected]John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07.

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

RFK Jr. spent three days at public events in Iowa this week. Send news tips and signs of a presidential run to [email protected] or John_Wilkerson.07 on Signal.Advertisement How Overton got picked The Trump administration wanted acting FDA Commissioner Kyle Diamantas to accept the job permanently.

He declined, so they went with Heidi Overton, Daniel Payne and Chelsea Cirruzzo report. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%! Request A Quote Request A Quote Savings start at 25%!

2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+. Subscribe Log In CDC, Donald Trump, FDA, HHS, Policy, RFK Jr., STAT+, White House Submit a correction requestReprints John Wilkerson Washington Correspondent John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter.

You can reach John on Signal at John_Wilkerson.07. Newsletter The latest updates in federal health agencies, research institutes, and U.S. policy Recommended The Readout August 20, 2026 STAT Plus: FDA approves Ultragenyx gene therapy The Readout August 19, 2026 STAT Plus: Experts scrutinize Huidagene’s disclosures after patient death Advertisement Business August 18, 2026 STAT Plus: Nonprofit health system raked in $1.1 billion this year from stake in medical billing firm The Readout August 18, 2026 STAT Plus: Real-world psilocybin data suggest need for close monitoring Hospitals August 18, 2026 STAT Plus: Leaders of Mass General, Dana-Farber among hospital execs who got big raises in 2024 Subscriber Picks